Prepared as a catalog companion to the model testing report.
Ingredient list
Declared composition for a LIRAVEXIN catalog item — not a tested result
Declared ingredients
| Ingredient | Amount as declared | Public identity |
|---|---|---|
| Tirzepatide | 100 mg | A dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Public sequence / structure: Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Aib-Leu-Asp-Lys-Ile-Ala-Gln-Lys(ε-(AEEA-AEEA-γ-Glu-eicosanedioic acid))-Ala-Phe-Val-Gln-Trp-Leu-Ile-Ala-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 |
| Other constituents | — | Not declared on the catalog label. No excipient (for example a bulking agent, counter-ion or residual moisture) is assumed here. |
Amino-acid sequences, where shown, are well-known public identities of the named substance. If a sequence could not be stated with confidence, it has been omitted rather than guessed.
Permalink
The QR code on the model report opens this page.
Published address:
https://gs-laboratory.com/ingredients/tr100.html
This is the published address of this ingredient list.
Notes
This ingredient list is a declared composition for the catalog item. It is not a Certificate of Analysis and not a statement of purity, identity or content as measured in a laboratory.
The catalog item is a research product, not a medicinal product. This page is not medical advice, not a dosing guide, and not a marketing claim. GS Laboratory does not manufacture or sell peptides or medicines.